Annals of Oncology
Q1 Journal
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Hematology
Q1
└
Medicine (miscellaneous)
Q1
└
Oncology
Q1
Publisher
SJR 2025
21.715
Q1
SJR Score
H-Index
331
Citations / Doc (2yr)
25.93
Total Docs. (latest)
244
Total Citations (3yr)
12,368
Publication type
Journals
ISSN
15698041, 09237534
Coverage
1990-2026
Journal Rank
#14
Subject Categories
Hematology
Q1
Medicine (miscellaneous)
Q1
Oncology
Q1
Subject Areas
Aims & Scope
Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies.
Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 244 |
| Total Docs. (3 years) | 471 |
| Total Refs. | 6,883 |
| Total Citations (3 years) | 12,368 |
| Citable Docs. (3 years) | 266 |
| Citations / Doc. (2 years) | 25.93 |
| Ref. / Doc. | 28.21 |
| % Female | 39.2% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Top 10 Most Cited Articles
Loading articles...